Full tissue-level effects generally take the length of the cycle, 4 to 12 weeks
Research demonstrates that copper ions can inhibit up to 90% of type 1 5-alpha reductase at specific concentrations
Breaks make sense for users experiencing treatment plateau where benefits cease increasing despite continued application suggesting diminishing returns from ongoing use, comfortable with some benefit decline during off periods accepting fluctuation in skin quality, budget-conscious seeking to minimize annual treatment costs through intermittent purchasing, philosophically preferring avoiding indefinite dependency on any skincare product, planning life changes incompatible with consistent application (extended travel, relocation, financial shifts), and wanting to assess whether improvements prove durable or require continuous maintenance before committing to indefinite treatment
ranging from 0 to 1) for each species
Still, the study points out that even though the results in animals are promising, more research is needed in humans to fully understand how safe and effective BPC-157 is and how it should be used
Cagrilintide hasnt been approved by the FDA